恒瑞医药10月29日耗资约442.77万元回购7万股A股

Core Viewpoint - Heng Rui Medicine (600276) announced a share buyback plan, intending to repurchase 70,000 A-shares at a cost of approximately 4.4277 million yuan by October 29, 2025 [1] Group 1 - The company plans to execute the buyback to enhance shareholder value and demonstrate confidence in its future prospects [1] - The total expenditure for the buyback is set at around 4.4277 million yuan, indicating a strategic move to utilize available capital [1] - The buyback involves 70,000 shares, reflecting a targeted approach to managing the company's equity [1]